Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Concern over SREs rises with increasing incidence of metastatic RCC

Umer M et al. Ann Med Surg. 2018 Jan 21. doi: 10.1016/j.amsu.2018.01.002

Key clinical point: As the incidence of metastatic renal cell carcinoma (RCC) continues to rise, knowledge of skeletal-related events and appropriate interventions is essential.

Major finding: About 85% of patients with metastatic RCC experience skeletal-related events and associated complications.

Study details: A literature review of skeletal metastasis in RCC.

Disclosures: The study did not receive specific funding.

Read the article.

Citation:

Umer M et al. Ann Med Surg. 2018 Jan 21. doi: 10.1016/j.amsu.2018.01.002